(Q34614357)

3 August 2017

1 reference

title

The lower the better? Reviewing the evidence for more aggressive cholesterol reduction and goal attainment (English)

1 reference

3 August 2017

Evan Stein

1

1 reference

3 August 2017

publication date

1 April 2002

1 reference

Atherosclerosis. Supplements

3 August 2017

published in

1 reference

3 August 2017

volume

2

1 reference

3 August 2017

issue

4

1 reference

3 August 2017

page(s)

19-23; discussion 23-5

1 reference

Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900020-4

7 January 2021

Twelve-year incidence of coronary heart disease in middle-aged adults during the era of hypertensive therapy: the Framingham offspring study.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900020-4

7 January 2021

Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900020-4

7 January 2021

The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900020-4

7 January 2021

Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900020-4

7 January 2021

Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900020-4

7 January 2021

Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial. Post CABG Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900020-4

7 January 2021

Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900020-4

7 January 2021

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900020-4

7 January 2021

Effect of rosuvastatin on low-density lipoprotein cholesterol in patients with hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900020-4

7 January 2021

Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2801%2900020-4

7 January 2021

10.1016/S1567-5688(01)00020-4

Identifiers

DOI

1 reference

3 August 2017

1 reference